[Asia Economy Reporter Lee Jung-yoon] Jungang Vaccine announced on the 3rd that its consolidated sales for the first quarter of this year amounted to 10.339 billion KRW, a 0.13% decrease compared to the same period last year.
Operating profit increased by 24.60% to 2.189 billion KRW, and net profit for the period rose by 37.05% to 2.249 billion KRW.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
